EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: A retrospective study

Thais Lizondo López, Belén López García, Neus Basté, Isabel Vilaseca, Juan José Grau, Esther Carcelero San Martín

Medicina Clínica · 2026

DOI: 10.1016/j.medcli.2025.107251 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medicina Clínica, 2026. Verfasst von Thais Lizondo López und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Service, Division of Medicines, University of Barcelona, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: tlizondo@clinic.ca…. Hauptthemen laut MEDLINE: Celecoxib, Cyclooxygenase 2 Inhibitors, Erlotinib Hydrochloride, Papillomavirus Infections. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CelecoxibCyclooxygenase 2 InhibitorsErlotinib HydrochloridePapillomavirus InfectionsRespiratory Tract InfectionsAdultFemaleHumansMaleMiddle AgedDrug Therapy, CombinationErbB ReceptorsRetrospective Studies

Stichwörter der Autor:innen

CelecoxibErlotinibHuman papillomavirusPapillomatosisPapilomatosisVirus papiloma humano

Substanzen

CelecoxibCyclooxygenase 2 InhibitorsErbB ReceptorsErlotinib Hydrochloride

Autor:innen und Institutionen

  • Pharmacy Service, Division of Medicines, University of Barcelona, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: tlizondo@clinic.cat.
  • Pharmacy Service, Division of Medicines, University of Barcelona, Hospital Clínic Barcelona, Barcelona, Spain.
  • Oncology Service, University of Barcelona, Hospital Clínic Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain.
  • Otorhinolaryngology Service, University of Barcelona, Hospital Clínic Barcelona, Barcelona, Spain; School of Medicine, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer,…
  • Oncology Service, University of Barcelona, Hospital Clínic Barcelona, Barcelona, Spain.

Zitieren

APA

López, T. L., García, B. L., Basté, N., Vilaseca, I., Grau, J. J., & Martín, E. C. S. (2026). Recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: A retrospective study. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.107251

Vancouver

López TL, García BL, Basté N, Vilaseca I, Grau JJ, Martín ECS. Recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: A retrospective study. Medicina Clínica. 2026. doi:10.1016/j.medcli.2025.107251

BibTeX
@article{Lpez2026,
  author = {López, Thais Lizondo and García, Belén López and Basté, Neus and Vilaseca, Isabel and Grau, Juan José and Martín, Esther Carcelero San},
  title = {Recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: A retrospective study},
  journal = {Medicina Clínica},
  year = {2026},
  doi = {10.1016/j.medcli.2025.107251}
}
Kostenlos starten →